CD274 and neoplasm: Seven hundred and sixty-three patients were enrolled in the study to investigate the role of SUVmax in lung cancer and 122 tumor specimens were analyzed by immunohistochemistry (IHC) to evaluate intra-tumor immune cells and PD-L1 expression in tumor cells.